NVO FY 2017 Earnings Report — Novo Nordisk A/S Revenue & Financial Results | Market Cap Arena

Novo Nordisk A/SNVO

FY 2017 Earnings

Reported December 30, 2017

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2017	Prior Q	FY 2016	QoQ Change	YoY Change
Revenue	$17.5B	—	$17.5B	—	-0.1%
Op. Income	$7.7B	—	$7.6B	—	1.1%
Gross Margin	84.2%	—	84.6%	—	-0.4pp
Net Margin	34.1%	—	33.9%	—	0.2pp
EPS (Diluted)	$1.21	—	$1.17	—	2.9%
Free Cash Flow	$5.1B	—	$6.3B	—	-18.8%

Revenue Flow

Item	Amount
REVENUE	$17.5B
Cost of Revenue	$2.8B
GROSS PROFIT	$14.7B
R&D Expenses	$2.2B
Selling & Marketing	$4.4B
General & Administrative	$593M
SG&A Expenses	$5.0B
Other Expenses	-$163M
Operating Expenses	$7.1B
Cost & Expenses	$9.8B
OPERATING INCOME	$7.7B
Interest Income	$11M
Interest Expense	$14M
Other Income/Expenses	-$45M
INCOME BEFORE TAX	$7.6B
Income Tax Expense	$1.7B
Net Income from Continuing Ops	$6.0B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$6.0B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$6.0B
D&A	$499M
EBIT	$7.6B
EBITDA	$8.1B
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$17.5B
Cost of Revenue	$2.8B
GROSS PROFIT	$14.7B
R&D Expenses	$2.2B
Selling & Marketing	$4.4B
General & Administrative	$593M
SG&A Expenses	$5.0B
Other Expenses	-$163M
Operating Expenses	$7.1B
Cost & Expenses	$9.8B
OPERATING INCOME	$7.7B
Interest Income	$11M
Interest Expense	$14M
Other Income/Expenses	-$45M
INCOME BEFORE TAX	$7.6B
Income Tax Expense	$1.7B
Net Income from Continuing Ops	$6.0B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$6.0B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$6.0B
D&A	$499M
EBIT	$7.6B
EBITDA	$8.1B
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$6.0B
Depreciation & Amortization	$499M
Stock-Based Compensation	$46M
Deferred Income Tax	$1.7B
Other Non-Cash Items	-$1.2B
Change in Working Capital	-$569M
OPERATING CASH FLOW	$6.4B
Capital Expenditure	-$1.4B
Acquisitions (Net)	$160M
Purchases of Investments	-$6M
Sales/Maturities of Investments	$326M
Other Investing Activities	-$155M
NET CASH FROM INVESTING	-$1.0B
Net Debt Issuance	$0
Common Stock Repurchased	-$2.6B
Common Dividends Paid	-$3.0B
Other Financing Activities	$0
NET CASH FROM FINANCING	-$5.6B
FREE CASH FLOW	$5.1B
Net Change in Cash	-$204M

Balance Sheet

Item	Amount
Cash & Equivalents	$3.0B
Short-Term Investments	$0
Net Receivables	$3.7B
Inventory	$2.4B
Other Current Assets	$891M
TOTAL CURRENT ASSETS	$9.4B
PP&E (Net)	$5.5B
Goodwill	$0
Intangible Assets	$521M
Long-Term Investments	$276M
Tax Assets	$304M
Other Non-Current Assets	$0
TOTAL NON-CURRENT ASSETS	$6.6B
TOTAL ASSETS	$16.0B
Account Payables	$879M
Short-Term Debt	$265M
Deferred Revenue	$6.2B
Other Current Liabilities	$4.7B
TOTAL CURRENT LIABILITIES	$7.4B
Long-Term Debt	$0
Deferred Revenue NC	$0
Deferred Tax Liabilities	$133M
Other Non-Current Liabilities	$727M
TOTAL NON-CURRENT LIABILITIES	$859M
TOTAL LIABILITIES	$8.2B
Common Stock	$78M
Additional Paid-In Capital	$0
Retained Earnings	$7.7B
Treasury Stock	-$2M
Accum. Other Comp. Income	$55M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$7.8B
Minority Interest	$0
TOTAL EQUITY	$7.8B
TOTAL LIABILITIES & EQUITY	$16.0B
Total Debt	$265M
Net Debt	-$2.7B